Desktop Scanners
PRODUCTS
-
Ensure safe and effective development of highly potent therapies with our proven expertise, specialized facilities, and robust containment systems designed to support every drug development stage.
-
PHCbi brand's 25.7 cu.ft (729L) ultra-low temperature freezer offers the flexibility of operating on both 115V or 220V with the switch of a power cord. This model provides enhanced security features and operates at only 5.40kWh per day. SMART features include three lock methods: facial recognition, keypad, or optional proximity card. ENERGY STAR® Certified.
-
The MPA1012 is a high-performance coax power amplifier designed for applications requiring a wide operating frequency range and significant output power.
-
Best-in-class contact centers serving life science organizations 24/7/365.
-
At Ideagen, we're committed to empowering seamless collaboration and enhancing your document review process. Through strategic alliances with leading technology providers across the life science industry, we offer integrations that amplify the efficiency and effectiveness of your workflows.
WHITE PAPERS AND CASE STUDIES
-
Advanced Mobile Lab For Rapid Disease Response
Discover how this mobile lab enhances rapid outbreak response and safely manages highly infectious pathogens, showcasing Germfree's expertise in biocontainment solutions for critical health crises.
-
Disinfection For Purified Water Loop For Kamada Pharmaceuticals, Israel
An Atlantium HOD™ (Hydro-Optic Disinfection) UV system was installed at the outlet of a PW tank to serve as the primary disinfection barrier, with water circulating through the system at 6m³/hr before reaching the points of use.
-
Pharma Custom Isolator For Sterile Lab Process
This project showcases Germfree’s capacity to provide cutting-edge, bespoke solutions in pharmaceutical manufacturing, underpinning their dedication to innovation, safety, and quality.
-
Formulation Development Of Enterically Protected Spray Dried Dispersions
Adrulipase spray-dried dispersions were evaluated to create an orally delivered, enteric-protected enzyme. The lead formulation provided the best acid protection, rapid release, and stability.
-
Elevating Diverse Patient Voices To Inspire Clinical Trial Participation
Explore the innovative approach taken during this clinical trial partnership to address the underrepresentation of minority communities in clinical trials through digital storytelling.
-
Pasteurized Equivalent Water For AgriMark-Cabot Dairy In Vermont
Discover how AgriMark-Cabot Dairy transformed wastewater into a valuable resource using UV technology, achieving significant energy and water savings while maintaining stringent food safety standards.
-
The Effect Of Mixing Homogeneity In Retentate Vessel
Discover a novel analytical method enhancing TFF diafiltration insights that deliver superior mixing, reliable scale-up, and breakthrough interpretation of diavolume performance.
-
Evaluating Milling Conditions For Scaling Up A Nanosuspension Drug Product
Aiming to obtain a target particle size to support Phase 3 clinical trials, uncover how this study contributed insights on nanosuspension drug product production at escalated scales.
-
Physiologix™ Serum Replacement Performance On Mesenchymal Stem Cells
Learn about the effectiveness of a xeno-free serum replacement in mesenchymal stem cell (MSC) culture and its potential to enhance cell growth and reduce variability compared to fetal bovine serum.
-
A Strategic Guide For Biotech And Biopharma Leaders
Securing drug approval is a complex, high-stakes process, and outdated review workflows hinder progress. Explore modern solutions that accelerate timelines without compromising compliance or quality.
-
Streamlining Study Start-Up For Accelerated Drug Development
What is the secret to safely expediting study start-ups? Explore our case study to find out how open dialogue, aligned expectations, and direct communication between Altasciences’ team leads and sponsor contributed to a clinical trial start-up of only 3.5 weeks.
-
Scalable Production Of High-Purity Nanobodies Using Yeast Expression System
Leverage scalable K. pastoris expression systems to produce high-quality nanobodies for cutting-edge therapeutic, diagnostic, and research applications.
NEWS
-
ArriVent BioPharma Enters Exclusive License With Lepu Biopharma For MRG007, An Antibody Drug Conjugate For The Treatment Of Gastrointestinal Cancers1/21/2025
ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP) a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced that it has entered into an exclusive license agreement with Lepu Biopharma Co., Ltd (Stock Code: 02157.HK) for MRG007, an antibody-drug conjugate (ADC) that can target several gastrointestinal (GI) cancers.
-
Taoglas Launches Thunder Series Integrated Antenna Enclosures To Simplify Router Installations And Cut Deployment Costs5/29/2025
Taoglas, a trusted provider of advanced antenna and IoT solutions, has launched its new Thunder Series – a high-performance outdoor antenna enclosure platform engineered to support direct integration and installation of the leading industrial routers within the antenna package.
-
Celiveo Enhances Celiveo 365 With Enterprise AI Document Management For Up To 1000% ROI1/2/2026
Celiveo, a global leader in high-security cloud print and document management solutions, today announced a major update to Celiveo 365 Enterprise Edition: the addition of enterprise-class AI-powered document management.
-
Webfleet Introduces Its New Driver Terminal PRO X: A Rugged, High-Performance Tablet For Fleet Professionals3/31/2025
Webfleet, Bridgestone’s globally trusted fleet management solution, is introducing its new flagship Driver Terminal: the PRO X.
-
Pulseforge Achieves Record Photonic Debonding Orders In Q1 2025, Signaling Market Acceleration4/29/2025
PulseForge, Inc., a global leader in high-intensity pulsed-light systems for semiconductor manufacturing, today announced a record volume of photonic debonding equipment orders in the first quarter of 2025.